Funding · Healthcare & Life Sciences

Gabify raises $175,000 pre-seed led by IPV

By Startup Enthusiast · 2 April 2026

What they do

Gabify provides an AI platform to screen and manage autism, ADHD, and other speech and neurological disorders

It raised $175,000 in pre-seed funding led by Inflection Point Ventures, plus a ₹25 lakh grant from GHRTBI

The platform uses dual-AI (voice and vision) and has been tested in 35+ preschools in India

Gabify announced a $175,000 pre-seed funding round led by Inflection Point Ventures on 2 April 2026.
It also received a ₹25 lakh grant under the Nidhi Seed Support Scheme from GHRTBI.
The company was founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk.
Gabify is described as India's first fully hosted SaaS ecosystem for speech and neurodevelopmental conditions.
Its platform uses dual-AI (voice and vision) to analyse speech patterns, facial expressions, eye gaze, and behaviours.
The system is aligned with 189+ clinically validated parameters from DSM-5 and CARS.
It follows a human-in-the-loop model where AI outputs are reviewed by clinical experts.
The platform has been tested in 35+ preschool and daycare centres in India during a private beta.

Autism prevalence has risen to 1 in 30 children post-COVID, creating urgent need for scalable screening.
India faces a shortage of therapists and long wait times, making AI-assisted tools critical.
The global market for such solutions is estimated at USD 110 billion with a ~15% CAGR.
Gabify's platform is designed for Bharat (rural India) with multilingual and low-bandwidth support.

Gabify offers an end-to-end AI screening and therapy management platform for autism, ADHD, and other speech and neurological disorders.
Its dual-AI technology analyses both voice and vision inputs to detect signs of neurodevelopmental conditions.
The platform uses 189+ clinically validated parameters based on DSM-5 and CARS standards.
It follows a human-in-the-loop model where clinical experts review AI outputs before final diagnosis.
The platform reduces assessment time by up to 70% compared to traditional methods.
Gabify serves schools, hospitals, private practices, and NGOs as its primary users.
It was tested in 35+ preschool and daycare centres in India during its private beta phase.
The platform is designed for Bharat (rural India) with multilingual and low-bandwidth capabilities.

Gabify will use the funds for clinical validation, technology enhancement, and team expansion.
It aims to impact 1 million children by 2028 through B2B, B2C, and CSR-led rollouts.

Inflection Point Ventures (lead) — Angel investing platform that has invested over INR 1200 crore across 280+ startups.

Product: AI-powered voice and vision analysis platform for early screening and therapy of autism, ADHD, and speech disorders
Customers: Preschools, schools, parents, and healthcare providers addressing neurodevelopmental disorder detection
How it makes money: B2B2C and B2C platform for clinical validation and therapy management
What sets it apart: Dual AI system combining voice and vision analysis with human-in-the-loop approach for clinical validation